2025-04-25
Hello and welcome to Clinical Trial Blazers, a podcast by Paracel Biotech,
where we explore the human stories behind breakthrough clinical research.
In this series, we take you inside the world of clinical development,
bringing you conversations with top voices from biotech.
Together, we will explore the pivotal choices, bold risks,
and remarkable achievements that define these trailblazers' legacies,
uncovering the heart, grit, and ingenuity driving the future.
of scientific innovation.
I am Alberto Grignolo, your host on this journey.
Whether you're a rising leader in biotech or simply curious about the future of clinical trials,
this series is here to inform, inspire, and spark your imagination.
Today, I'm talking with Robert Blum, President and CEO of Sato Kinetics in South San Francisco,
a biopharmaceutical company that develops therapies for heart failure,
hypertrophic cardiomyopathy, and ALS.
based on the science of muscle biology.
Robert, welcome.
Delighted to be with you.
Thank you.
It's a pleasure to be with you.
Let's start from the beginning.